Teva Pharmaceutical and Chemical (Hangzhou) Co. Ltd.

Close-out letter issued April 25, 2018 · Hangzhou, China

Pages
1
FEI number
3009271645

In short: On April 25, 2018, FDA sent Teva Pharmaceutical and Chemical (Hangzhou) Co. Ltd. in Hangzhou, China (FEI 3009271645) a close-out letter, confirming that the issues in an earlier warning letter were addressed.

Inside this close-out letter

The full close-out letter

Every page of the close-out letter, exactly as written.

Get the full close-out letter

This inspection in context

Questions about this close-out letter

When was Teva Pharmaceutical and Chemical (Hangzhou) Co. Ltd. inspected by FDA?

This Close-out letter is dated April 25, 2018.

How do I get the full Close-out letter for Teva Pharmaceutical and Chemical (Hangzhou) Co. Ltd.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free